"Indolizines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
No definition found.
| Descriptor ID |
D007212
|
| MeSH Number(s) |
D03.633.100.496
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Indolizines".
Below are MeSH descriptors whose meaning is more specific than "Indolizines".
This graph shows the total number of publications written about "Indolizines" by people in this website by year, and whether "Indolizines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 1 | 0 | 1 |
| 2016 | 0 | 1 | 1 |
| 2019 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
| 2025 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Indolizines" by people in Profiles.
-
Dinaciclib improves treatment response in chemoresistant hepatoblastoma. Sci Rep. 2025 Dec 05; 16(1):1410.
-
Epigenetic Targeting of TERT-Associated Gene Expression Signature in Human Neuroblastoma with TERT Overexpression. Cancer Res. 2020 03 01; 80(5):1024-1035.
-
CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer. Nat Commun. 2019 11 08; 10(1):5114.
-
Multiple CDK inhibitor dinaciclib suppresses neuroblastoma growth via inhibiting CDK2 and CDK9 activity. Sci Rep. 2016 07 05; 6:29090.
-
Synthesis of the indolizino[7,6-c]quinoline alkaloid isaindigotidione. Org Lett. 2010 Oct 15; 12(20):4628-31.
-
Antitumor agents 252. Application of validated QSAR models to database mining: discovery of novel tylophorine derivatives as potential anticancer agents. J Comput Aided Mol Des. 2007 Jan-Mar; 21(1-3):97-112.